Related Experiment Video
Updated: Mar 26, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Epidemiology and Mechanisms of Uremia-Related Cardiovascular Disease
Marcello Tonelli1, S Ananth Karumanchi2, Ravi Thadhani2
1From Department of Medicine, University of Calgary, AB, Canada (M.T.); Department of Medicine and Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, and Howard Hughes Medical Institute, Chevy Chase, MD (S.A.K..); and Division of Nephrology, Massachusetts General Hospital, Harvard Medical School, Boston (R.T.). tonelli.admin@ucalgary.ca.
Insights
Patients with chronic kidney disease (CKD) face a significantly higher risk of cardiovascular disease (CVD). Uremia-specific factors, beyond traditional risks, drive CVD in CKD patients, necessitating targeted research and improved management strategies.
Area of Science:
- Nephrology
- Cardiology
- Epidemiology
Background:
- Patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) exhibit a 5- to 10-fold increased risk of cardiovascular disease (CVD) compared to age-matched individuals.
- CVD in this population presents as coronary artery disease, arrhythmias, stroke, and congestive heart failure.
- Traditional risk factors like diabetes and hypertension are compounded by uremia-specific factors from toxin accumulation in the pathogenesis of CVD.
Purpose of the Study:
- To review the epidemiology of traditional and uremia-related CVD in CKD patients.
- To explore the postulated mechanisms of uremia-specific CVD pathogenesis.
- To identify gaps in current CVD diagnostics and therapies for CKD patients and suggest future research directions.
Main Methods:
- Literature review of epidemiological studies on CVD in CKD.
- Analysis of postulated mechanisms linking uremia to CVD.
- Evaluation of current and emerging CVD diagnostics and therapies in the context of CKD management.
Main Results:
- CKD and ESRD significantly elevate CVD risk.
- Uremia-specific factors play a crucial role in CVD development in these patients.
- Significant gaps exist in the medical management of CVD in the growing CKD population.
Conclusions:
- Targeted epidemiological and translational research is essential to address the gaps in managing CVD in CKD patients.
- Global challenges in recognizing and managing uremia-related CVD require attention in both developed and developing nations.
- A comprehensive approach integrating understanding of traditional and uremia-specific factors is needed for effective CVD management in CKD.
Abstract:
Patients with chronic kidney disease and end-stage renal disease are at 5- to 10-fold higher risk for developing cardiovascular disease (CVD) than age-matched controls. Clinically, CVD in this population manifests as coronary artery disease, arrhythmias, stroke, or congestive heart failure. Beyond the traditional risk factors (eg, diabetes mellitus and hypertension), uremia-specific factors that arise from accumulating toxins also contribute to the pathogenesis of CVD. In this review, we summarize the literature on the epidemiology of both traditional and uremia-related CVD and focus on postulated mechanisms of the latter. In the context of current and emerging diagnostics and therapies for CVD, we highlight what we interpret as major gaps in the medical management of this growing population that need to be addressed with targeted epidemiological and translational research. Finally, we describe the global challenges associated with the recognition and management of uremia-related CVD in developed and developing nations.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Hypertension and Regulation of Blood Pressure
Pathophysiology of Heart Failure
Acute Kidney Injury II: Pathophysiology

